Objective To analyze Ambroxol Hydrochloride effectiveness of adjuvant treatment of neonatal pneumonia conventional medicine. Methods 70 cases of neonatal pneumonia from February 2014 to April 2015 in our hospital were selected,and according the use of sequential parity law hospitalized. they were randomly divided into control group (n=35) and observation group (n=35), control group with conventional treatment, observation group were based on the control group treatment by Mucosolvan. neonatal crackles subsided time, cooling time, hospitalization and clinical efficacy of the two groups were compared. Results The experimental group crackles subsided time, cooling time, hospital stay were shorter than the control group (P<0.01), the test group, the total effective rate was 91.4%, significantly higher than 82.9% (P<0.05). Conclusion Mucosolvan in treatment of neonatal pneumonia can effectively improve the clinical symptoms observed improvement in time, improve efficiency, its secondary treatment of neonatal effects should be affirmed.%目的：分析盐酸氨溴索（沐舒坦）辅助常规用药治疗新生儿肺炎的疗效。方法选择2014年2月～2015年4月我院收治的70例新生儿肺炎患者，采用入院顺序奇偶法，将其随机分为对照组（n=35）及观察组（n=35），对照组采用常规治疗，观察组在对照组基础上予以沐舒坦治疗，比较患儿湿啰音消退时间、退热时间、住院时间及临床疗效情况。结果试验组湿啰音消退时间、退热时间、住院时间均显著短于对照组（P ＜0.01）；试验组总有效率为91.4%，高于对照组82.9%（P ＜0.05）。结论沐舒坦佐治新生儿肺炎能有效提高观察组临床症状改善时间，提高有效率，其辅助治疗新生儿肺炎的效果值得肯定。
展开▼
